Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Tapentadol IR vs Oxycodone IR in Chronic Pain
NCT00364546Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Jul 2006
- Primary completion
- Jun 2007
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of tapentadol in chronic pain, low back pain (LBP), osteoarthritis of the hip, knee osteoarthritis (OA), sponsored by Johnson & Johnson. Started Jul 2006; status: completed.
02
Drugs
tapentadol
03
Conditions
chronic painlow back pain (LBP)osteoarthritis of the hipknee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00364546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00364546.